Sexual Health Peptides

Sexual Health Peptide Research

Sexual health peptides represent an expanding frontier in clinical research, targeting the neuroendocrine pathways that govern arousal, desire, and reproductive function. Unlike conventional pharmacological approaches that act on vascular mechanisms, peptides such as PT-141 (Bremelanotide) and Kisspeptin-10 work through melanocortin and GnRH receptor systems in the central nervous system, offering a fundamentally different mechanism of action. This category includes peptides studied for libido modulation, hormonal signaling, and skin pigmentation research.

Key Research Highlights

• PT-141 is the only peptide-based compound FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women
• Kisspeptin-10 acts upstream on GnRH neurons, making it a target for both fertility and desire research
• Melanotan II activates MC4R receptors, studied for both tanning and libido-enhancing effects
• Oxytocin research explores its role in pair bonding, social behavior, and sexual arousal modulation
• All products in this category are 99%+ purity, third-party lab tested with published COA

Product Comparison

Peptide	Primary Target	Receptor	Dosage	Research Focus
PT-141 (Bremelanotide)	Central nervous system	MC4R	10mg	Sexual desire, arousal modulation
Kisspeptin-10	Hypothalamus GnRH neurons	KISS1R	10mg	Reproductive signaling, fertility
Melanotan II	Melanocortin system	MC1R / MC4R	10mg	Pigmentation, libido enhancement
Melanotan I	Melanocyte stimulation	MC1R	10mg	Skin pigmentation, photoprotection
Oxytocin	Hypothalamic neurons	OXTR	10mg	Social bonding, arousal research

How Sexual Health Peptides Work

Unlike PDE5 inhibitors that act on peripheral blood flow, sexual health peptides modulate desire and arousal at the neurological level. This distinction is critical for researchers studying the difference between mechanical and psychological components of sexual function.

Current Research Applications

1. Hypoactive Sexual Desire Disorder (HSDD) - PT-141 has completed Phase III trials and received FDA approval under the brand name Vyleesi for premenopausal women with acquired, generalized HSDD
2. Male Erectile Dysfunction - Melanocortin agonists are under investigation as alternatives for patients who do not respond to PDE5 inhibitors, targeting central rather than peripheral pathways
3. Reproductive Endocrinology - Kisspeptin-10 is studied as a diagnostic and therapeutic tool in conditions involving GnRH deficiency and hypothalamic amenorrhea
4. Social Behavior Research - Oxytocin continues to be a major focus in behavioral neuroscience, with studies examining its role in trust, empathy, and pair bonding
5. Photoprotection - Melanotan I (afamelanotide) has been investigated for erythropoietic protoporphyria (EPP), with key differences from Melanotan II in receptor selectivity and side-effect profile

Reconstitution & Dosing

All lyophilized peptides in this category require bacteriostatic water for reconstitution before use. Researchers can use our reconstitution calculator and dosage calculator to determine precise volumes. For proper injection technique and syringe selection, see the syringe unit calculator.

Research Use Only: All peptides listed in this category are sold exclusively for legitimate research purposes. They are not intended for human consumption, medical treatment, or diagnostic use. Researchers should consult institutional guidelines and applicable regulations. View our quality assurance page for purity and testing documentation.